Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies

Yunqing Lin, Ziyun Xiao, Fangxiao Hu, Xiujuan Zheng, Chenyuan Zhang, Yao Wang, Yanhong Liu, Dehao Huang, Zhiqian Wang, Chengxiang Xia, Qitong Weng, Leqiang Zhang, Yaoqin Zhao, Hanmeng Qi, Yiyuan Shen, Yi Chen, Fan Zhang, Jiaxin Wu, Pengcheng Liu, Jiacheng Xu, Lijuan Liu, Yanping Zhu, Jingliao Zhang, Wenbin Qian, Aibin Liang, Xiaofan Zhu, Tongjie Wang, Mengyun Zhang, Jinyong WangJournal of Hematology & Oncology 2025 · DOI

Abstract

Our study provides a reliable strategy for the large-scale generation of fratricide-resistant CD7 CAR-iNK cells with robust anti-tumor effects from hPSCs, offering a promising cell product to treat T-cell malignancies.
BibTeX
@article{lin2025engineered,
  author = {Yunqing Lin and Ziyun Xiao and Fangxiao Hu and Xiujuan Zheng and Chenyuan Zhang and Yao Wang and Yanhong Liu and Dehao Huang and Zhiqian Wang and Chengxiang Xia and Qitong Weng and Leqiang Zhang and Yaoqin Zhao and Hanmeng Qi and Yiyuan Shen and Yi Chen and Fan Zhang and Jiaxin Wu and Pengcheng Liu and Jiacheng Xu and Lijuan Liu and Yanping Zhu and Jingliao Zhang and Wenbin Qian and Aibin Liang and Xiaofan Zhu and Tongjie Wang and Mengyun Zhang and Jinyong Wang},
  title = {{Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies}},
  journal = {Journal of Hematology \& Oncology},
  year = {2025},
  doi = {10.1186/s13045-025-01712-3},
}

Loading related content...

Figure